Marília O. F. Goulart

Prof. Marília O. F. Goulart

Institute of Chemistry and Biotechnology, Federal University of Alagoas, Maceió, Alagoas, Brazil
orcid
Full Professor

Research Focus & Metrics

Academic Career Length

47Years (1980-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 June 2021 in Antioxidants
Verified
Journal Article
Open access
PDF file
Micaely TenórioMicaely Tenório
Micaely Tenório
NGNayara Gomes Graciliano
Nayara Gomes Graciliano
FMFabiana Andréa Moura
Fabiana Andréa Moura
AOAlane Cabral Menezes de Oliveira
Alane Cabral Menezes de Oliveira
Marília O. F. GoulartMarília O. F. Goulart
Marília O. F. Goulart
N-acetylcysteine (NAC) is a medicine widely used to treat paracetamol overdose and as a mucolytic compound. It has a well-established safety profile, and its toxicity is uncommon and dependent on the route of administration and high dosages. Its remarkable antioxidant and anti-inflammatory capacity is the biochemical basis used to treat several diseases related to oxidative stress and inflammation. The primary role of NAC as an antioxidant stems from its ability to increase the intracellular concentration of glutathione (GSH), which is the most crucial biothiol responsible for cellular redox imbalance. As an anti-inflammatory compound, NAC can reduce levels of tumor necrosis factor-alpha (TNF-α) and interleukins (IL-6 and IL-1β) by suppressing the activity of nuclear factor kappa B (NF-κB). Despite NAC’s relevant therapeutic potential, in several experimental studies, its effectiveness in clinical trials, addressing different pathological conditions, is still limited. Thus, the purpose of this chapter is to provide an overview of the medicinal effects and applications of NAC to human health based on current therapeutic evidence.

1 December 2015 in Redox Biology
Verified
Journal Article
Open access
FMFabiana Andréa Moura
Fabiana Andréa Moura
KAKívia Andrade
Kívia Andrade
JSJuliana Célia Farias dos Santos
Juliana Célia Farias dos Santos
OAOrlando Roberto Pimentel Araújo
Orlando Roberto Pimentel Araújo
Marília O. F. GoulartMarília O. F. Goulart
Marília O. F. Goulart
Oxidative stress (OS) is considered as one of the etiologic factors involved in several signals and symptoms of inflammatory bowel diseases (IBD) that include diarrhea, toxic megacolon and abdominal pain. This systematic review discusses approaches, challenges and perspectives into the use of nontraditional antioxidant therapy on IBD, including natural and synthetic compounds in both human and animal models. One hundred and thirty four papers were identified, of which only four were evaluated in humans. Some of the challenges identified in this review can shed light on this fact: lack of standardization of OS biomarkers, absence of safety data and clinical trials for the chemicals and biological molecules, as well as the fact that most of the compounds were not repeatedly tested in several situations, including acute and chronic colitis. This review hopes to stimulate researchers to become more involved in this fruitful area, to warrant investigation of novel, alternative and efficacious antioxidant-based therapies.

1 March 2004 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
VAValter Andrade-Neto
Valter Andrade-Neto
Marília O. F. GoulartMarília O. F. Goulart
Marília O. F. Goulart
JFJorge F da Silva Filho
Jorge F da Silva Filho
MSMatuzalém J da Silva
Matuzalém J da Silva
MPMaria Do Carmo F.R Pinto
Maria Do Carmo F.R Pinto
AKAntoniana U Krettli
Antoniana U Krettli

Verified
Journal Article
Open access
PDF file
KAKívia Andrade
Kívia Andrade
FMFabiana Andréa Moura
Fabiana Andréa Moura
JSJohn Marques Dos Santos
John Marques Dos Santos
OAOrlando Pimentel DE ARAUJO
Orlando Pimentel DE ARAUJO
JSJuliana Célia De Farias Santos
Juliana Célia De Farias Santos
Marília O. F. GoulartMarília O. F. Goulart
Marília O. F. Goulart
Liver disease is highly prevalent in the world. Oxidative stress (OS) and inflammation are the most important pathogenetic events in liver diseases, regardless the different etiology and natural course. N-acetyl-l-cysteine (the active form) (NAC) is being studied in diseases characterized by increased OS or decreased glutathione (GSH) level. NAC acts mainly on the supply of cysteine for GSH synthesis. The objective of this review is to examine experimental and clinical studies that evaluate the antioxidant and anti-inflammatory roles of NAC in attenuating markers of inflammation and OS in hepatic damage. The results related to the supplementation of NAC in any form of administration and type of study are satisfactory in 85.5% (n = 59) of the cases evaluated (n = 69, 100%). Within this percentage, the dosage of NAC utilized in studies in vivo varied from 0.204 up to 2 g/kg/day. A standard experimental design of protection and treatment as well as the choice of the route of administration, with a broader evaluation of OS and inflammation markers in the serum or other biological matrixes, in animal models, are necessary. Clinical studies are urgently required, to have a clear view, so that, the professionals can be sure about the effectiveness and safety of NAC prescription.

16 December 2019 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
LFLucas José Sá da Fonseca
Lucas José Sá da Fonseca
VNValéria Nunes-Souza
Valéria Nunes-Souza
Marília O. F. GoulartMarília O. F. Goulart
Marília O. F. Goulart
LRLuiza Antas Rabelo
Luiza Antas Rabelo
Numerous rheumatologic autoimmune diseases, among which rheumatoid arthritis, are chronic inflammatory diseases capable of inducing multiple cumulative articular and extra-articular damage, if not properly treated. Nevertheless, benign conditions may, similarly, exhibit arthritis as their major clinical finding, but with short-term duration instead, and evolve to spontaneous resolution in a few days to weeks, without permanent articular damage. Such distinction—self-limited arthritis with no need of immunosuppressive treatment or chronic arthritis at early stages?—represents one of the greatest challenges in clinical practice, once many metabolic, endocrine, neoplastic, granulomatous, infectious diseases and other autoimmune conditions may mimic rheumatoid arthritis. Indeed, the diagnosis of rheumatoid arthritis at early stages is a crucial step to a more effective mitigation of the disease-related damage. As a prototype of chronic inflammatory autoimmune disease, rheumatoid arthritis has been linked to oxidative stress, a condition in which the pool of reactive oxygen species increases over time, either by their augmented production, the reduction in antioxidant defenses, or the combination of both, ultimately implying compromise in the redox signaling. The exact mechanisms through which oxidative stress may contribute to the initiation and perpetuation of local (in the articular milieu) and systemic inflammation in rheumatoid arthritis, particularly at early stages, still remain to be determined. Furthermore, the role of antioxidants as therapeutic adjuvants in the control of disease activity seems to be overlooked, as a little number of short studies addressing this issue is currently found. Thus, the present review focuses on the binomialrheumatoid arthritis-oxidative stress, bringing insights into their pathophysiological relationships, as well as the implications of potential diagnostic oxidative stress biomarkers and therapeutic interventions directed to the oxidative status in patients with rheumatoid arthritis.

4 November 2019 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
MTMarilene Brandão Tenório
Marilene Brandão Tenório
RFRaphaela Costa Ferreira
Raphaela Costa Ferreira
FMFabiana Andréa Moura
Fabiana Andréa Moura
NBNassib Bezerra Bueno
Nassib Bezerra Bueno
AOAlane Cabral Menezes de Oliveira
Alane Cabral Menezes de Oliveira
Marília O. F. GoulartMarília O. F. Goulart
Marília O. F. Goulart
The occurrence of hypertensive syndromes during pregnancy leads to high rates of maternal-fetal morbidity and mortality. Amongst them, preeclampsia (PE) is one of the most common. This review aims to describe the relationship between oxidative stress and inflammation in PE, aiming to reinforce its importance in the context of the disease and to discuss perspectives on clinical and nutritional treatment, in this line of research. Despite the still incomplete understanding of the pathophysiology of PE, it is well accepted that there are placental changes in pregnancy, associated with an imbalance between the production of reactive oxygen species and the antioxidant defence system, characterizing the placental oxidative stress that leads to an increase in the production of proinflammatory cytokines. Hence, a generalized inflammatory process occurs, besides the presence of progressive vascular endothelial damage, leading to the dysfunction of the placenta. There is no consensus in the literature on the best strategies for prevention and treatment of the disease, especially for the control of oxidative stress and inflammation. In view of the above, it is evident the important connection between oxidative stress and inflammatory process in the pathogenesis of PE, being that this disease is capable of causing serious implications on both maternal and fetal health. Reports on the use of anti-inflammatory and antioxidant compounds are analysed and still considered controversial. As such, the field is open for new basic and clinical research, aiming the development of innovative therapeutic approaches to prevent and to treat PE.